Marizoza Fousteri

Learn More
OBJECTIVES Available data on colistin pharmacokinetics in patients undergoing continuous renal replacement therapy (CRRT) are limited. Our aim was to study colistin pharmacokinetics in critically ill patients treated with colistin methane sulphonate for Gram-negative sepsis and undergoing continuous venovenous haemodiafiltration for acute renal failure. (More)
is also little doubt that technologic and human capabilities will continue to improve and that improvements in patients' outcomes will follow. The point of our editorial was not to argue against research and innovation, quite to the contrary. Our view is simply that the lessons of the worldwide 2009 infl uenza A(H1N1) epidemic do not support a costly,(More)
  • 1